Identification and External Validation of a Transcription Factor-Related Prognostic Signature in Pediatric Neuroblastoma

Figure 3

Characteristics of the prognostic model consisting of eight TFs in the TARGET dataset. (a) Kaplan–Meier survival analysis of the TF-based prognostic models. (b) Distribution of survival times of neuroblastoma patients. (c) Distribution of risk scores of neuroblastoma patients. (d) The AUC value reflects the high prognostic accuracy of the TF-based signature. (e) Distribution of the expression values of TFs in the model.

(a)

(b)

(c)

(d)

(e)